ACCESS ALL ASIA: Speedier approvals available soon in China - for a fee
This article was originally published in Clinica
Executive Summary
With China in the midst of rolling out a raft of new medtech regulations, medtech manufacturers have to go through more hoops to get their product approved. Now, companies also have to contend with forking out a substantial sum to the China Food and Drug Administration in registration fees.